ROLLAMIDE_A;MAJOR_ISOMER
Compound with spectra: 2 NMR
| SpectraBase Compound ID | 31TjEimmXVX |
|---|---|
| InChI | InChI=1S/C41H61N7O7/c1-7-26(6)34-38(52)43-29(23-27-14-9-8-10-15-27)40(54)47-20-11-17-31(47)36(50)44-33(25(4)5)41(55)48-21-13-16-30(48)35(49)42-28(22-24(2)3)39(53)46-19-12-18-32(46)37(51)45-34/h8-10,14-15,24-26,28-34H,7,11-13,16-23H2,1-6H3,(H,42,49)(H,43,52)(H,44,50)(H,45,51)/t26?,28-,29-,30-,31-,32-,33-,34-/m0/s1 |
| InChIKey | MRHPZOQSYDFOLJ-QSQGNRBVSA-N |
| Mol Weight | 764.0 g/mol |
| Molecular Formula | C41H61N7O7 |
| Exact Mass | 763.463247 g/mol |
| Enantiomer InChIKey | MRHPZOQSYDFOLJ-OXGIIYSLSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | C5D5N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | C5D5N |
- ROLLAMIDE_A;MINOR_ISOMER
PHAKELLISTATIN_18;CYCLO-(L-PRO-L-TYR-L-PRO-L-ILE-L-PHE-L-PRO-L-ILE)
PHAKELLISTATIN-2;CYCLO-(TYR-PRO-PHE-PRO-ILE-ILE-PRO)
PHAKELLISTATIN-2;LESS-POLAR-CONFORMER
DIANTHIN-B
PSEUDACYCLIN_A;CYCLO-[N-(DELTA)-L-ORN-(1)-(N-1-ACETYL-L-ILE-(6))-D-PHE-(2)-L-PRO-(3)-L-ILE-(4)-L-ILE-(5)]
COTTESLOSIN_B;COMPOUD-#3
CHERIMOLACYCLOPEPTIDE-G;CYCLO-(GLYCYL-ALANYL-VALYL-PROLYL-ISOLEUCYL-TYROSINYL-ALANYL-PROLYL)
COTTESLOSIN_A;COMPOUD-#2
GYPSOPHIN-A;CYCLO-[PROLINE(1)-TYROSINE(2)-SERINE(3)-PHENYLALANINE(4)-PHENYLALANINE(5)-VALINE(6)-ISOLEUCINE(7)-GLUTAMINE(8)]
PSEUDOSTELLARIN-H;CYCLO-(GLY-THR-PRO-THR-PRO-LEU-PHE-PHE)
| Title | Journal or Book | Year |
|---|---|---|
| Rolloamides A and B, Cytotoxic Cyclic Heptapeptides Isolated from the Caribbean Marine Sponge Eurypon laughlini | Journal of Natural Products | 2009 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.